A comparison of two injection approaches for rectus sheath block in laparoscopic inguinal hernia repair

A comparison of two injection approaches for rectus sheath block in laparoscopic inguinal hernia repair - A comparison of two injection approaches for rectus sheath block in laparoscopic inguinal hernia repair

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043712

Enrollment

Registered

2021-04-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia

Interventions

0.25% levobupivacaine 48mL administration into the rectus abdominis muscle under ultrasound guidance, before skin incision. Ultrasound-guided rectus abdominis sheath block, with 0.25% levobupivacain

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients weighing 50-80kg, with American Society of Anesthesiologists physical status 1-2, who underwent laparoscopic inguinal hernia repair.

Exclusion criteria

Exclusion criteria: Patients with coagulation disorder, impaired hepatic or renal function, and abnormal platelet counts were excluded from the study.

Design outcomes

Primary

Measure	Time frame
pain level (numerical rating scale), and nausea at 1, 4, 6, and 12 hours after completion of surgery	—

Secondary

Measure	Time frame
the time from the nerve block to the first additional analgesic dose number of additional analgesic doses	—

Countries

Japan

Contacts

Public ContactHiroshi Aoki

Nagasaki Rosai Hospital Department of anesthesia

hiroshia@terra.dti.ne.jp0956-49-2191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026